CINA CHEST vs Cleerly ISCHEMIA
AI Verdict
Choose CINA CHEST if…
Choose CINA CHEST if your primary need is rapid, AI-powered triage and notification for acute, life-threatening chest conditions like Pulmonary Embolism (PE) and Aortic Dissection (AD) in an emergency setting. This tool is ideal for quickly flagging suspected positive findings on CT angiography scans to prioritize urgent cases and streamline emergency radiology workflows.
View CINA CHEST →Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if you require a comprehensive, non-invasive AI analysis of CCTA scans to determine the likelihood of coronary artery ischemia at a vessel level. This tool is best suited for detailed personalized diagnosis, treatment planning, and understanding coronary plaque characteristics and stenosis severity in patients with suspected or known heart disease.
View Cleerly ISCHEMIA →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CINA CHEST | Cleerly ISCHEMIA |
|---|---|---|
| Pricing | Subscription-based | Contact for details |
| Deployment | Cloud-based, On-premise (dedicated hardware), Virtualized (VM, Docker) | Web-based platform; data transfer via Cleerly Proxy (VPN or virtual appliance) |
| FDA Status | K210237 AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CINA CHESTCINA CHEST, particularly with the recent launch of Avicenna.AI's AVI platform, emphasizes a 'fast, automatic, and invisible' integration directly into existing PACS and RIS without requiring new viewers, worklists, or workflow changes. This focus on minimal disruption and no extra training for clinicians suggests a superior user experience for rapid triage in emergency settings.
Clinical Value
CINA CHESTCINA CHEST provides rapid detection and prioritization of life-threatening conditions like Pulmonary Embolism (PE) and Aortic Dissection (AD), with reported mean time-to-notification as low as 36.5 seconds for AD. Its role in emergency triage directly impacts immediate patient outcomes by flagging critical findings for urgent intervention.
Pricing & Value
Cleerly ISCHEMIAWhile both tools require contacting for specific pricing, Cleerly ISCHEMIA offers more transparency by mentioning its billability under Category I CPTu00ae Codes 75580 and 75577, with a global reimbursement rate of $1,026 for plaque analysis (CPT 75577) as of 2026. This provides clearer guidance for providers on potential reimbursement and economic value.
Enterprise Readiness
CINA CHESTCINA CHEST offers more flexible deployment options including cloud-based, on-premise, and virtualized environments, catering to diverse IT infrastructures. Furthermore, Avicenna.AI's AVI platform is designed for seamless integration with existing PACS/RIS, supporting global interoperability standards like DICOM, HL7, and FHIR, and is built for GDPR- and HIPAA-compliant workflows across various healthcare settings.
Innovation
Cleerly ISCHEMIACleerly ISCHEMIA demonstrates a deeper innovation by non-invasively estimating fractional flow reserve (FFR) and providing detailed coronary plaque characterization (volume, type, location), moving beyond anatomical assessment to functional ischemia. This comprehensive approach aims to redefine heart disease diagnosis and personalize treatment planning, with studies showing a reduction in further invasive testing and an increase in preventive medications.
Support & Docs
CINA CHESTWhile both companies offer customer support, Avicenna.AI specifically mentions 'Avicenna Scribe for Customer support' which includes features like summaries, QA tagging, and QA escalation triggers for every call. This suggests a more structured and potentially proactive approach to managing and improving support interactions.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CINA CHEST | Cleerly ISCHEMIA |
|---|---|---|
| Tool Name | CINA CHEST | Cleerly ISCHEMIA |
| Company | Avicenna.AI | Cleerly |
| Primary Clinical Focus | Rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans. | Analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. |
| Core Functionality 1 | Radiological computer-aided triage and notification. | AI-enabled CCTA analysis for non-invasive ischemia detection. |
| Core Functionality 2 | Detection of Pulmonary Embolism (PE) and Aortic Dissection (AD). | Vessel-level ischemia likelihood determination and coronary plaque characterization. |
Videos
Demos, reviews, and walkthroughs featuring CINA CHEST and Cleerly ISCHEMIA.
Frequently Asked Questions
More Comparisons
More matchups featuring CINA CHEST or Cleerly ISCHEMIA
Backers
Who funded each tool's parent company.